Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Moclobemide in social phobia
European Archives of Psychiatry and Clinical Neuroscience, 05/13/08
Katschnig H - The results indicate that 600 mg of moclobemide per day given b.i.d. is effective in social phobia, reducing the symptoms and the impairment associated with the disorder. The compound is well tolerated and safe.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Denosumab update
Current Opinion in Rheumatology, 06/11/09
Dapsone 5 Gel: A Review of its Efficacy and Safety in the Treatment of Acne Vulgaris
American Journal of Clinical Dermatology, 06/09/09
Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation
European Journal of Clinical Investigation, 06/01/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Sudden Death and Use of Stimulant Medications in Youths
American Journal of Psychiatry, 06/16/09
Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
Journal of Psychopharmacology, 06/10/09
The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS
Journal of Affective Disorders, 06/22/09
Article Search
Sponsor


See Latest Articles


